I

INmune Bio
D

INMB

2.33000
USD
0.17
(7.83%)
مفتوح الان
حجم التداول
4,488
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
64,666,328
أصول ذات صلة المقالات
المزيد

العنوان: INmune Bio

القطاع: الرعاية الصحية
الصناعة: Biotechnology
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.